Committee 4: workshop on experimental chemotherapy of leprosy.
出版信息
Int J Lepr Other Mycobact Dis. 1979 Jun;47(2 Suppl):297-303.
PMID:378876
Abstract
摘要
相似文献
1
Committee 4: workshop on experimental chemotherapy of leprosy.委员会4：麻风病实验化疗研讨会
Int J Lepr Other Mycobact Dis. 1979 Jun;47(2 Suppl):297-303.
2
[Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].[麻风病的抗菌化疗：原则、目标与建议]
Acta Leprol. 1986 Jul-Sep;4(3):355-62.
3
Multi-drug therapy of leprosy.麻风病的联合化疗
Indian J Lepr. 1985 Jul-Sep;57(3):465-82.
4
Dapsone drug resistance in the MDT era.多药联合治疗时代的氨苯砜耐药性。
Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):323-5.
5
Screening of drugs for activity against Mycobacterium leprae.筛选抗麻风分枝杆菌活性的药物。
Int J Lepr Other Mycobact Dis. 1987 Dec;55(4 Suppl):836-42.
6
Recent trends in chemotherapy of leprosy.麻风病化疗的近期趋势
J Assoc Physicians India. 1985 Sep;33(9):593-5.
7
[Drug resistance of Mycobacterium leprae].[麻风分枝杆菌的耐药性]
Acta Leprol. 1986 Jul-Sep;4(3):279-87.
8
Drug resistance in leprosy: lessons from past and future perspective.麻风病的耐药性：过去与未来视角的经验教训
Indian J Lepr. 1999 Oct-Dec;71(4):451-63.
9
Evolution of the modern chemotherapy of leprosy.麻风病现代化学疗法的演变
Lepr Rev. 1983 Jun;Spec No:69-83. doi: 10.5935/0305-7518.19830050.
10
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.一株对氨苯砜、利福平、氧氟沙星和司帕沙星耐药的麻风分枝杆菌分离株。
Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):452-5.
Zotero 插件